Anastrozole (Arimidex ™) – an aromatase inhibitor for the adjuvant setting?
2001
Anastrozole: A New Treatment for Breast Cancer
publication
Evidence: high
Author Information
Author(s): Buzdar A U
Primary Institution: MD Anderson Cancer Center, University of Texas
Hypothesis
Can anastrozole provide better treatment outcomes than tamoxifen for early breast cancer in postmenopausal women?
Conclusion
Anastrozole shows superior efficacy and tolerability compared to tamoxifen for treating hormone-sensitive advanced breast cancer.
Supporting Evidence
- Anastrozole is a potent aromatase inhibitor that suppresses estrogen levels effectively.
- It has been shown to be superior to tamoxifen in treating advanced breast cancer.
- Anastrozole is well tolerated and has a convenient once-daily dosing regimen.
Takeaway
Anastrozole is a medicine that helps treat breast cancer better than some older medicines, and it's easy for patients to take.
Methodology
The study involved a major clinical program comparing anastrozole to tamoxifen in postmenopausal women with hormone-sensitive advanced breast cancer.
Participant Demographics
Postmenopausal women with hormone-sensitive advanced breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website